Since Hahn demonstrated the clearing of alimentary lipemia by the intravenous injection of heparin, many excellent studies have been done on lipoprotein lipase (LPL). In these studies, however, LPL activities were compared in normal and pathological conditions at a certain time after heparin injection. If the level of LPL activity in the circulating blood changes continuously after heparin injection, under the influences of production and inactivation of LPL, it may be much more useful, under certain circumnstances, to measure the rate of change as well as the amount of such activity.
Since Hahn demonstrated the clearing of alimentary lipemia by the intravenous injection of heparin, many excellent studies have been done on lipoprotein lipase (LPL). In these studies, however, LPL activities were compared in normal and pathological conditions at a certain time after heparin injection. If the level of LPL activity in the circulating blood changes continuously after heparin injection, under the influences of production and inactivation of LPL, it may be much more useful, under certain circumnstances, to measure the rate of change as well as the amount of such activity.
One of the authors reported previously (1) the method of estimating the release or production rate and inactivation rate of LPL after heparin injection. This report will present the data on the metabolism of LPL activity in blood after the intravenous injection of heparin in normal subjects and patients with liver diseases, obesity, and coronary sclerosis, and in some animals.
EXPERIMENTAL METHODS
Preparation of materials. Human subjects and experimental animals were fasted overnight before the experiment. Experimental animals (dogs and rabbits) were anesthetized with pentobarbital sodium (Nembutal) just before use.
Heparin injection. The doses of heparin injected were 0.1 mg per kg of body weight throughout the experiment. The injection was done rapidly into the antecubital vein in men and dogs and into the ear vein in rabbits.
Withdrawals of blood. At certain intervals after the injection, blood was withdrawn from the antecubital vein in human subj ects, from the femoral vein in dogs, and by heart puncture in rabbits. The blood specimen was immediately added to 1/9 vol of Y/10 M sodium oxalate solution kept in an ice-water bath.
Assay of LPL activity. The test plasma weas obtained by centrifuging the blood for 5 minutes at 4,000 rpm in the cold. The substrate consisted of 0. Immediately after the mixing of 1 ml of test plasma with 1.5 ml of substrate, 1.0 ml of the mixture was pipetted into Dole's extraction mixture, and the remainder was incubated at 390 C for 30 minutes. The LPL activity was expressed by the difference of FFA concentrations (microequivalents per liter) in the mixture before and after the incubation. FFA was measured by Dole's method (2) . The details of our method were discussed in the previous paper (1) .
RESULTS AND DISCUSSION
LPL activity curve in normnal human beings, dogs, and rabbits. Eight healthy men aged 25 to 35 years, 4 dogs, and 3 rabbits were used. Figures 1 and 2 show the changes of LPL activity as a function of time in human subjects and dogs, respectively. Similar changes of LPL activity were observed also in rabbits. The rapid rise in LPL activity was observed immediately after heparin injection, and the peak was after about 9 minutes in human subjects, about 8 minutes in dogs, and about 3 minutes in rabbits. Thereafter, the activity fell at a constant rate, linearly on the logarithmic scale.
If: 1) heparin (H0 milligrams per kilogram of body weight) is injected instantly; 2) the disappearance of heparin from the circulating blood is governed by the rate constant a; 3) LPL is produced in proportion to the amount of heparin in the blood (proportional constant c); and 4) LPL is inactivated at the constant rate b, then the changes of LPL activity, L, in the circulating blood may be expressed as follows: L = [cH,/ (a -b)] (e-bt-e-aC). The validity of this equation was discussed in detail in our previous paper (1) , and also may be judged from the fitness of the theoretical curve to experimental data in Fig-1 The results are shown in Table I . The a's and K's in Table I were calculated by using the average tmax value (time when the maximal LPL activity curve value was obtained) of the normal subjects. i.e., 9.1 minutes. Judged from curve analysis, this assumption may be reasonable.
The mean half-life of LPL in the circulation was 39.0 minutes in liver cirrhosis, which was significantly longer than that in normal subjects (p < 0.01).2 In cases of acute hepatitis, except one, the half-lives were almost the same as that of the normal subjects, and the mean value was not different from that of the control. In hepatic cancer and liver abscess, the half-life was identical with the normal value.
Constantinides, So, and Johnstone (3) and Baker, Levine, Turner, and Dubin (4) observed the higher LPL activity in the postheparin blood in liver cirrhosis and experimental liver damages and suggested that the ability to inactivate LPL was decreased in these hepatic disorders. Connor and Eckstein (5) confirmed these findings by assaying LPL activities in cannulated blood from the hepatic and systemic veins, the same as that of the portal vein in respect to LPL activity. The results of our experiment also support these findings.
In general, the rate of LPL inactivation in the liver may depend on the number of functioning liver cells, the function of each liver cell, hepatic blood flow, and the combinations of all or some of these.
In liver cirrhosis, the decrease in hepatic blood flow might play the most important role in the observed decrease in the rate of LPL inactivation.
In acute hepatitis, although hepatic blood flow had been reported to be decreased only slightly (6), the decreased inactivation of LPL was expected. In agreement with our results, however, Baker and associates (4) (5) and Kern and Sanders (7).
Judged from the K's in Table I , the rate of release of LPL from the peripheral tissues (expressed by c) was markedly lower in patients with liver diseases, even when the half-life of LPL was normal, as in the cases of acute hepatitis. Sandhofer and co-workers (8) suggested also that the low LPL activity in patients with liver diseases might be due to the decreased release of LPL, but not to any inhibitor in the circulation.
Experimental studies on the role of the liver in the inactivation of LPL. Jeffries (9) and Spitzer and Spitzer (10) found that LPL was destroyed in the liver. But as mentioned above, unexpectedly in acute hepatitis the rate of inactivation of LPL seemed to be normal. Therefore, in order to examine the role of the liver in the inactivation of LPL, the following experiments were performed.
Functional hepatectomy was performed on a dog and two rabbits under Nembutal anesthesia by ligating portal vein, hepatic artery, and common bile duct together. In the dog, the rate of LPL inactivation was only about 7%o of that of normal dogs (ti, 257 minutes; Figure 2 ). In rabbits, the average rate of LPL inactivation was only about 6%o of that of normal rabbits (t1, 94 minutes; Figure 3 By treating animals either with allyl form-iate (periportal fatty degeneration) or with carbon tetrachloride (centrolobular), the inhibitory effects of the liver homogenates were reduced in all fractions to about 75% of those of the normal liver homogenates (Table II) kade of the reticuloIt is unknown whether the increased ability of formed in rabbits by inactivating LPL is concerned with the develops of 5 ml per 1 kg of ment of obesity. 3which was diluted LPL activity curve in atherosclerotic patients. line solution.
The LPL activity curves were determined in five inese ink usually lost patients with coronary sclerosis. The half-life Therefore, the control of LPL was 21.0 + 3.17 minutes, with a significant ed rabbits were fasted difference from the control group (0.02 < p < 0.05) ( Table I) . as mentioned in the Methods section. and LPL activity curves were obtained. Reticuloendothelial blockade did not influence the LPL activity curve in the circulation (Table I) . The parenchymal cells, not Kupffer's cells, seemed, therefore, to inactivate LPL in the liver.
Mitochondrial fraction and supernatant fluid were obtained from mice livers by the method of Stein, Tietz, and Shapiro (11) . The inhibitory effect of these fractions on LPL activity of heparinized human plasma was examined by preincubating 1 ml of heparinized plasma with 1 ml of each fraction and then determining residual LPL activitv bv the above-mentioned method. The 3 Kaimei Bokujyu, Taguchi Co., Ltd., Tokyo, Japan. been intensively studied by many investigators as related to atherosclerosis. Some (12) (13) (14) (15) (16) (17) observed lower LPL activity in patients with atherosclerosis, but others (8, (18) (19) (20) (21) (22) found no difference in LPL activity between normal and atherosclerotic subjects. Our results showed that the peak values were the same in both groups.
Whether the observed increase in the rate of inactivation of LPL is concerned with the occurrence of atherosclerosis remains to be solved.
CONCLUSION
The levels of lipoprotein lipase (LPL) activity were followed for a period of time after heparin injection, and the metabolism of LPL in the circulating blood was studied from the dynamic point of view. The results were as follows:
1) The LPL activity rose rapidly to reach the peak at about 9 minutes in man, about 8 minutes in dogs, and about 3 minutes in rabbits. The LPL activity curve was expressed by the difference of 2) The mean half-life of LPL in the circulation was 25.4 minutes in man, 18.6 minutes in dogs, and 7.3 minutes in rabbits.
3) The average of calculated half-life of injected heparin was 2.4 minutes in man, 2.3 minutes in dogs, and 0.7 minutes in rabbits.
4) The mean half-life of LPL activity in patients with liver cirrhosis was significantly longer than the normal value, while that in acute hepatitis, liver abscess, and liver cancer was normal. Calculated production rate of LPL was lower in liver diseases.
5) Functional hepatectomy in a dog and rabbits inhibited almost completely the inactivation of LPL in the circulation.
6) The blockade of the reticuloendothelial system by Chinese ink did not influence the LPL activity curve in the circulation. There was 3 times higher inhibitory activity on LPL in mitochondria than in the supernatant fluid of the mouse liver.
7) The rate of LPL inactivation in the circulation was significantly shorter in obesity and in coronary sclerosis.
